Silzle, T., Blum, S., Schuler, E., Kaivers, J., Rudelius, M., Hildebrandt, B., . . . Germing, U. (2019). Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients. Blood Cancer J.
Chicago Style CitationSilzle, Tobias, Sabine Blum, Esther Schuler, Jennifer Kaivers, Martina Rudelius, Barbara Hildebrandt, Norbert Gattermann, Rainer Haas, i Ulrich Germing. "Lymphopenia At Diagnosis Is Highly Prevalent in Myelodysplastic Syndromes and Has an Independent Negative Prognostic Value in IPSS-R-low-risk Patients." Blood Cancer J 2019.
Cita MLASilzle, Tobias, et al. "Lymphopenia At Diagnosis Is Highly Prevalent in Myelodysplastic Syndromes and Has an Independent Negative Prognostic Value in IPSS-R-low-risk Patients." Blood Cancer J 2019.